Authors
Latest:
Edward Wild, MBBChir, PhD, MA: Generation HD1 Study of RG6042The neurologist at the Huntington’s Disease Center at University College London spoke about the clinical development of RG6042 in the treatment of Huntington disease, and what to expect from the GENERATION HD1 study.
Latest:
William Tatum, DO: When to Obtain a Routine EEG While Managing a Patient with EpilepsyThe neurologist and epileptologist at the Mayo Clinic in Jacksonville spoke about how to best identify adult patients in need of routine EEG and what it will bring to the table relative to the clinician.
Latest:
The Future of HD TreatmentDaniel Claassen, MD, MS, reviews emerging treatment options for HD, and shares resources for patients, caregivers, and physicians to navigate diagnosis and management of HD.
Latest:
Peter Goadbsy, MD, PhD, DSc: Atogepant Has Potential as Migraine ProphylacticThe professor of neurology at both the University of California San Francisco and King’s College, London, spoke about the results from a phase 2b/3 study evaluating atogepant for prevention of migraine.
Latest:
CNM-Au8 as a Novel Therapeutic Category in MS: Robert Glanzman, MDThe chief medical officer at Clene Nanomedicine discussed the recently presented data on CNM-Au8 from the VISIONARY-MS trial.
Latest:
Striking Differences in the Treatment of Parkinson Disease in the Last DecadeIn honor of Parkinson Disease Awareness Month, Hubert Fernandez, MD, director of the Center for Neurological Restoration at Cleveland Clinic, provided perspective on the advances in the care for the neurodegenerative disorder.
Latest:
Future Directions for the Management of NarcolepsyMargaret Park, MD, and Russell Rosenberg, PhD, DABSM, provide clinical pearls and the future treatment landscape for the management of narcolepsy.v
Latest:
Spinal Muscular Atrophy and COVID-19: Guidance and Resources for ProvidersAdvocacy organization Cure SMA provides guidance for health care providers caring for patients with SMA during the ongoing COVID-19 pandemic.
Latest:
Analyzing Cognitive Profiles in Multiple Sclerosis and Alzheimer Disease: Le Hua, MDThe director of the Multiple Sclerosis Program at the Cleveland Clinic’s Lou Ruvo Center for Brain Health discussed findings from a study that compared cognitive profiles between patients with multiple sclerosis and Alzheimer disease. [WATCH TIME: 5 minutes]
Latest:
Ruth Ann Marrie, MD, PhD: Role of Comorbidities in MSThe professor of medicine and community health sciences at the University of Manitoba spoke about the effects of comorbidity on diagnosis, outcomes, and treatment in multiple sclerosis.
Latest:
Practical Advice for Managing Morning OFF Episodes in Parkinson DiseaseClosing out his review of on-demand therapies for morning OFF episodes in Parkinson disease, Peter A. LeWitt, MD, shares practical advice for community neurologists.
Latest:
A Conversation on Women's Leadership and Career in Medicine: Jennifer Frontera, MDThe professor of neurology at NYU Grossman School of Medicine talked about the importance of aligning leadership roles with personal passions for women in the field of neurology pursuing their careers in medicine. [WATCH TIME: 5 minutes]
Latest:
AI-Powered Patient Advocacy: Amplifying Health Care VoicesAI could revolutionize patient advocacy by bridging communication gaps between patients and providers, and the synergy of medicine and AI offers a promising avenue for enhanced patient care and operational efficiency.
Latest:
Richard Lipton, MD: Interpreting Eptinezumab's Impact on HIT-6 ScoreThe director of the Montefiore Headache Center will provide further insight into migraine care at the 1st Annual International Congress on the Future of Neurology, to be held September 27-28 in New York City.
Latest:
Rodolfo Savica, MD, PhD: Dyskinesias in Atypical ParkinsonismThe associate professor of neurology at Mayo Clinic spoke about the findings of a population-based cohort study seeking to investigate the incidence of levodopa-induced dyskinesia in atypical parkinsonism.
Latest:
Laura Julian, PhD: The Floodlight Open MS DatabaseThe principal medical science director at Genentech spoke about the decisions behind the tools being used for measurement, and what the neurologists can get from the data.
Latest:
Laura T. Safar, MD: Carefully Addressing Mental Health in MSThe director of MS neuropsychiatry at Brigham and Women’s Hospital spoke of the importance of not oversimplifying the approach to mental health disorders in individuals with MS, and how the collaborative care model can help.­­­
Latest:
Reena Mehra, MD, MS: Advances in Sleep Apnea Treatment DevicesThe director of the Sleep Disorders Research Program at Cleveland Clinic Lerner College of Medicine detailed the advancements that have been made with OSA treatment devices.
Latest:
David Holtzman, MD: Difficulties Identifying Dementia With Lewy BodiesThe current president of the American Neurological Association specifically mentioned the work some groups are doing with small molecule imaging methods to help with this issue.
Latest:
Irina Pikuleva, PhD: Activating CYP46A1 with EfavirenzThe Carl F. Asseff Professor of Ophthalmology and the Director of the Visual Sciences Research Center at Case Western Reserve University spoke about the beginnings of her work with efavirenz.
Latest:
Changes Needed to Improve SMA Costs: Lisa Belter, MPHThe director of research analytics at Cure SMA detailed the ways to decrease care management costs for patients with spinal muscular atrophy and the role incoming treatments can play.
Latest:
Concluding Thoughts on Biosimilars in Multiple SclerosisAmy Perrin Ross, APN, Patricia Melville, NP-C, Aliza Ben-Zacharia, PhD, DNP, ANP-BC, and John Kramer, PA-C share their advice for facilitating uptake of biosimilars in clinical practices.
Latest:
The Brisk Evolution of Multiple Sclerosis CareWe are closer than ever to individualized management of MS, and keeping up with the rapidly changing pace of MS care is challenging even for an MS specialist.
Latest:
New Horizons in Multiple SclerosisExperts share insights on the latest innovations in multiple sclerosis research, in highlights from a recent State of the Science SummitTM, presented by Neurology Live®.
Latest:
Zachary Grinspan, MD, MS: Improving Adherence to Status Epilepticus ProtocolsThe director of the Pediatric Epilepsy Program is joined by an MD candidate from Weill Cornell Medicine to discuss the protocol used to treat patients with status epilepticus.
Latest:
Pierrick Arnal, PhD: Conducting Sleep Studies With the Dreem HeadbandThe vice president of science and medical at Dreem offered his opinion on how the company’s headband device can improve how sleep studies are conducted.
Latest:
Potential Layered Migraine Treatment Approaches to Research: Andrew Blumenfeld, MDThe director of the Headache Center of Southern California discussed research opportunities for layered treatment approaches in migraine.
Latest:
James Hendrix, PhD: Progress and Challenges in the Alzheimer SpaceHendrix spoke to the challenges he and colleagues come across, as well as his hope for the promising future.
Latest:
Spinal Muscular Atrophy and COVID-19: Guidance and Resources for ProvidersAdvocacy organization Cure SMA provides guidance for health care providers caring for patients with SMA during the ongoing COVID-19 pandemic.
